281 related articles for article (PubMed ID: 25490895)
1. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.
Antony-Debré I; Manchev VT; Balayn N; Bluteau D; Tomowiak C; Legrand C; Langlois T; Bawa O; Tosca L; Tachdjian G; Leheup B; Debili N; Plo I; Mills JA; French DL; Weiss MJ; Solary E; Favier R; Vainchenker W; Raslova H
Blood; 2015 Feb; 125(6):930-40. PubMed ID: 25490895
[TBL] [Abstract][Full Text] [Related]
2. Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model.
Borst S; Nations CC; Klein JG; Pavani G; Maguire JA; Camire RM; Drazer MW; Godley LA; French DL; Poncz M; Gadue P
Stem Cell Reports; 2021 Jun; 16(6):1458-1467. PubMed ID: 34019812
[TBL] [Abstract][Full Text] [Related]
3. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
Bluteau D; Gilles L; Hilpert M; Antony-Debré I; James C; Debili N; Camara-Clayette V; Wagner-Ballon O; Cordette-Lagarde V; Robert T; Ripoche H; Gonin P; Swierczek S; Prchal J; Vainchenker W; Favier R; Raslova H
Blood; 2011 Dec; 118(24):6310-20. PubMed ID: 21725049
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
[TBL] [Abstract][Full Text] [Related]
6. Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.
Connelly JP; Kwon EM; Gao Y; Trivedi NS; Elkahloun AG; Horwitz MS; Cheng L; Liu PP
Blood; 2014 Sep; 124(12):1926-30. PubMed ID: 25114263
[TBL] [Abstract][Full Text] [Related]
7. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.
Jalagadugula G; Mao G; Kaur G; Goldfinger LE; Dhanasekaran DN; Rao AK
Blood; 2010 Dec; 116(26):6037-45. PubMed ID: 20876458
[TBL] [Abstract][Full Text] [Related]
8. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
[TBL] [Abstract][Full Text] [Related]
9. Human
Li Y; Jin C; Bai H; Gao Y; Sun S; Chen L; Qin L; Liu PP; Cheng L; Wang QF
Blood; 2018 Jan; 131(2):191-201. PubMed ID: 29101237
[TBL] [Abstract][Full Text] [Related]
10. Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q.
Shinawi M; Erez A; Shardy DL; Lee B; Naeem R; Weissenberger G; Chinault AC; Cheung SW; Plon SE
Blood; 2008 Aug; 112(4):1042-7. PubMed ID: 18487507
[TBL] [Abstract][Full Text] [Related]
11. Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways.
Fortschegger K; Husa AM; Schinnerl D; Nebral K; Strehl S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299194
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
Schlegelberger B; Heller PG
Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
[TBL] [Abstract][Full Text] [Related]
13. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.
Ganly P; Walker LC; Morris CM
Leuk Lymphoma; 2004 Jan; 45(1):1-10. PubMed ID: 15061191
[TBL] [Abstract][Full Text] [Related]
14. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
[TBL] [Abstract][Full Text] [Related]
15. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.
Béri-Dexheimer M; Latger-Cannard V; Philippe C; Bonnet C; Chambon P; Roth V; Grégoire MJ; Bordigoni P; Lecompte T; Leheup B; Jonveaux P
Eur J Hum Genet; 2008 Aug; 16(8):1014-8. PubMed ID: 18478040
[TBL] [Abstract][Full Text] [Related]
16. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
[TBL] [Abstract][Full Text] [Related]
17. An inherited variant of transcription factor RUNX1 related to thrombocytopenia with predisposition to acute myeloid leukaemia.
Tian Y; Jia SX; Shi J; Fang MY
Int J Lab Hematol; 2019 Dec; 41(6):e128-e129. PubMed ID: 31034769
[No Abstract] [Full Text] [Related]
18. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
19. Generation of a human induced pluripotent stem cell line, IMSUTi002-A-1, harboring the leukemia-specific fusion gene ETV6-RUNX1.
Takahashi M; Yamazaki S
Stem Cell Res; 2019 Oct; 40():101546. PubMed ID: 31476588
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects.
Stockley J; Morgan NV; Bem D; Lowe GC; Lordkipanidzé M; Dawood B; Simpson MA; Macfarlane K; Horner K; Leo VC; Talks K; Motwani J; Wilde JT; Collins PW; Makris M; Watson SP; Daly ME;
Blood; 2013 Dec; 122(25):4090-3. PubMed ID: 24100448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
